How brain tumors escape the effects of antiangiogenic drugs

A study reveals details of a way the dangerous brain tumors called glioblastomas resist the effects of antiangiogenic drugs designed to cut off their blood supply, identifying what may be a new treatment target.

Leave a Reply

Your email address will not be published. Required fields are marked *